agºÍ¼Ç

À´Ô´£ºÍì»ØÍì»Ø  £¬×÷Õߣº  £¬£º

ุúÄ㽲࣠ £¬¹ðÁÖ³ÇÀïÍ·ÄÇЩÀϵط½  £¬½²Õæ  £¬ÕæÊÇÔ½°áÔ½ÈÃÈËÕÒ²»×ű±ÁË¡£¾ÍÏñ֮ǰµÄÀ³É½Îç̨СÏï×Ó  £¬Ïëµ±ÄêßÖ  £¬ÄÇÀï³ÔµÄºÈµÄ¼òÖ±ÊÇˬµ½ÂѶ¼µø¡£ºÃ¶àÈËÌØµØ´Ó±ð¸öµØ·½ÅÜÀ´  £¬¾ÍΪÁ˳¢³¢Õý×ڵĹðÁÖζµÀ¡£°¥Ó´  £¬ÏÖÔÚÌý½²°áÁË  £¬¸ãµÃÈ˶¼ÔÚÎÊ£º¾¿¾¹°áµ½ÄÄ¿­È¥ÁË£¿ÏÂÃæßÖ  £¬ÎҺúøúÄã´µÒ»ÂÖ  £¬¿´ÄãÏþµÃûÄÇЩÄÚÄ»ÏûÏ¢ßÖ¡£

À³É½Îç̨СÏï×ÓÒÔǰÊǸö¸£µØ  £¬°¤ÂÑÃÍ£¡

ÏȽ²¸ö࣠ £¬ÒÔǰÄǸöСÏï×ÓÀïÍ·°¡  £¬ÕæµÄÊÇɶ¶¼ÓС£Ã×·ÛµêßÖ  £¬Â±Î¶Ì¯ßÖ  £¬ÉÕ¿¾Ì¯ßÖ  £¬Á¬ÂôÌÇÓÍôÎôεÄÀϰ¢ÆÅ¶¼ÔÚÄDZßÔúÁ˸ù¡£È˼Ò˵³Ô»õµÄÌìÌà  £¬ÂÑû´í£¡ÌرðÊÇÄǸöÒ¹ÊÐ  £¬¶ªÄÇÐÇ  £¬²îµãûÅŶÓÅŵ½·èÁË¡£Óиã¸öÃ×·Û̯×Ó  £¬Â±Ë®ÏãµÃÂÑë¶¼µß  £¬³ÔÒ»¿ÚÄã¾ÍÏþµÃΪʲôÄÇô¶àÈËÉá²»µÃÀ뿪¡£

Ïà¹ØÍ¼Æ¬

²»¹ýßÖ  £¬ØÊºóÌý½²ÊÇÒòΪҪ¸ïР £¬¸ãµÃÕû¸öÏï×Ó¶¼²ðÁË¡£ÄÇЩÀϰåÒ²ÊÇ  £¬Ã»µÃ²½·¥  £¬Ö»Äܰá×ß¡£½²ÆðÕâ¸öÊÂ࣠ £¬ÕæÊÇÓеãÐÄÍ´  £¬ÏñÊǰÇÀô¬Ò»Ñù  £¬¸ãµÃÒ»µØ¼¦Ã«  £¬³Ô»õÃǶ¼¿ÞÁË¡£¶Ô²î³Øà££¿Äã½²ÊDz»ÊǸü×Ó£¿

ÏÖÔÚ°áµ½ÄÄ¿­È¥ÁË£¿Äã¸ãÂÑû¼û£¿

ÎÒ¹À¶ÑÓ´  £¬Ðí¶àÈ˶¼ÔÚÎÊÕâ¸öÎÊÌâ¡£ÄãÏþµÃû  £¬ÏÖÔÚÄÇЩÀϰåÃÇËÆºõÊǰᵽÏóÉ½ÇøÄÇÒ»´øÈ¥ÁË  £¬¾ßÌåλÖÃÂï  £¬Ìý½²ÊÇÔÚÆßÐÇ·ËÄÖܵÄпªÉÌÒµ½Ö¡£Äã¿ËÄÇÀïתһȦ  £¬Óи㼸¸öÀÏÊìÈËÔÚÄÇ  £¬»¹ÄܳԵ½ÒÔǰµÄζµÀ  £¬ÂѺúȵÄÃ×·ÛÕÕ¾ÉÓÐ  £¬Â±Î¶Ò²ÊÇÇõð¸Ü  £¬Äã¿ÉÒÔÊÔÏÂ×Ó¡£

ÐÑÁúµã£º¿ËÆßÐÇÄDZß×îºÃÂéÖ±×ßµ½ºóÃæµÄÏï×Ó  £¬Ã»È»ÂÑÕÒ²»µ½¡£Òª²»È»»¹ÒÔΪÄÇЩÀϰ嶼ûÂÑÀí¿ªµêÁË¡£

Äܲ»¿É³Ôµ½ÒÔǰÄÇÖÖζµÀßÖ£¿ÂÑÊǵģ¡

ุúÄ㽲࣠ £¬Î¶µÀÕÕ¾ÉÓеã·×ÆçÑùµÄ¡£ËäÈ»ÄÇЩÀÏ°å´ø×Å×Ô¼ºµÄÊÖÒպ͹øÍëÆ°ÅèÈ¥ÁËеط½  £¬µ«È˼ҽ²Çé¿ö·×ÆçÑùÁË  £¬¸ÐÊÜÒ²»á±äµÃÓеã²î³ØÍ·¡£²»¹ýßÖ  £¬ÂÑÊÇµÄ  £¬Ã×·ÛÕÕ¾ÉÃ×·Û  £¬Â±Ë®Õվɱˮ  £¬³ÔÆðÕÕ¾ÉÓÐÄÇÖÖÊìϤµÄζµÀ¡£¾¿¾¹ÊÇÀϹðÁÖµÄζµÀ  £¬ËãÂÑÃÍÁË  £¬ÖµµÃ¿ËÊÔÏÂ×Ó¡£

²»¹ýÎÒÌý½²  £¬ÓÐЩÀϰ廹Ïë»ØÀ´Ô­µØ¿ªµê  £¬µ«µØ·½³Ù³Ùû¸ãºÃ¡£ÕæµÄÊǸãÂÑû¼û  £¬À˲ÙÐÄÇ飡²»¹ýÄãÒ²±ð¼±  £¬µÈ¹ýÒ»¶Îʱ¼ä  £¬¿ÉÄÜ»áÓÐÐÂÏûÏ¢¡£½²µ½ÕâÀïßÖ  £¬ÄãÒªÊÇʵÔÚ²öÁË  £¬¸Ïæ¿ËÆßÐÇÄDZßÕһصãζµÀ°É¡£


Ïà¹ØÍ¼Æ¬

ÄǾ¿¾¹À³É½Îç̨СÏï×ÓµÄÀϰåÃǰáÄÄ¿­È¥ÁË£¿ÂÑÓö¼Ã»£¡Äã¾Í¼Ç×ÅÒ»µã£ºÆßÐÇ·ËÄÖÜпªÉÌÒµ½Ö  £¬¼°Ôç¿Ë  £¬±ð¸ãÂÑû¼û¡£

À³É½Îç̨СÏï×Ó, ¹ðÁÖÃÀʳ, Àϵط½°á¼Ò, ÆßÐÇ·ÃÀʳ, ¹ðÁÖÌØÉ«

Ïà¹ØÍ¼Æ¬

¡¶º£¿ÚÄĸöÏï×ÓÓÐÅ®ÈË¡·

¡°×÷ΪÐÐÒµÊ׸öÐÔÄÜUltra  £¬ÕâÊÇÎÒÃÇÀúʱ7ÄêΪËûÃÇÁ¿Éí´òÔìµÄáÛ·åÖ®×÷  £¬Ëü²»Êǵü´ú  £¬Ô½·¢²»ÊÇÉý¼¶  £¬¶øÊÇÖØ¹¹£¡ÎÒÃÇÖØ¹¹ÐÔÄÜÏëÏó  £¬Öع¹²Ù¿Ø¼«ÏÞ  £¬Öع¹ÓÎÏ·Ö±²¥ÌåÑé  £¬Öع¹¿Æ¼¼ÃÀѧÉè¼Æ  £¬ÈÃÕâ´úоƬÊͷųöÏÂÒ»´úµÄÐÔÄÜ¡£ÊÇÎÒÃÇÀú¾­7Äê̽Ë÷  £¬·ºÆð¸ø¼«ÖÂÍæ¼ÒµÄËÄ·ÝÍêÃÀ´ð¾í¡£¡±Ëû˵¡£

¡¶ÀÈ·»Ô¼ÃÀÅ®¡·

ÍôãüÌáÐÑ  £¬µ¥·½ÃæÃâÇ©Õþ²ß¡°ÀûºÃ¡±  £¬µ«Ò²±£´æÈÈÞ°µãÔ¤Ô¼ÓÐÄѶÈ£»Ïû·ÑÖ§¸¶ÈÔÐèÓÅ»¯  £¬³öÐйºÎﻹ²»·ó±ã½ÝµÈÎÊÌâ¡£

¡¶Ê¯¼Òׯºó½ÖÅ®ÈË×î¶àÔÚÄĶù¡·

δÀ´ 3¨C5 Äê  £¬ÖØµã¹Ø×¢¼à¹ÜÓë¹¤ÒµÑØÆ½Ì¨Ö÷ÎļþºÍ¸ö°¸ÊÊÅäÑݽø  £¬ÏȶԱ༭Æ÷ÓëµÝËÍÔØÌ彨Á¢¿É¸´ÓõķÇÁÙ´²Óë CMC ¿ò¼Ü  £¬ÔÙÓÃСÐÐÁÐ/ÀºÊ½ÊÔÑéÓëÕæÊµÊÀ½çÖ¤¾ÝÀ©Õ¹ÊÊÓùæÄ£¡£FDA ½üÆÚÌá³öµÄ¡°plausible mechanism pathway£¨¿ÉÖÃÐÅ»úÖÆÂ·¾¶£©¡±ÕýÊͷųöÃ÷È·Ðźţºµ±Ëæ»ú±ÈÕÕ²»¿ÉÐÐʱ  £¬¼à¹Ü¿ÉÄܸüÇ¿µ÷»úÖÆ¿É½âÊÍÐÔÓë¿ÉÊÓ²ìµÄÁÙ´²¸ÄÉÆ  £¬Í¬Ê±ÒªÇóÉÏÊкóÁ¬ÐøÖ¤¾Ý²¹È«¡£

¡¶ÉÌÇð200ÔªÈýСʱЧÀÍ¡·

ÉÏÖ¤±¨ÖйúÖ¤È¯ÍøÑ¶£¨¼ÇÕßµËÕ꣩1ÔÂ18ÈÕ  £¬ÔÚÖ£ÖݾÙÐеġ°È˹¤ÖÇÄÜ+¡±ÓëÊý×Ö¾­¼ÃÖªÃûÉÏÊй«Ë¾ÆóÒµ¼ÒºÓÄÏÐÐÔ˶¯ÉÏ  £¬»ªÔƿعɶ­Ê³¤ÑÕÏþ±õ½éÉÜÁ˹«Ë¾Ö÷ÓªÒµÎñ  £¬²¢±í´ïÁËÔÚÖ£Öݼ°ºÓÄÏѰÇóÏàÖúµÄÒâÏò¡£ÑÕÏþ±õÌåÏÖ  £¬»ªÔƵÄÒµÎñÖ÷Òª¼¯ÖÐÔÚÁ½´ó°å¿é£ºÒ»ÊÇÒÔ¿Í»§Ð§ÀÍ×÷ÒµÖÐÐÄΪ½¹µãµÄ¹¤ÒµÁ´£»¶þÊÇͶ×Ê¡£

ÍøÕ¾µØÍ¼